(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.35%) $91.45
-84.62% $ 0.000200
Live Chart Being Loaded With Signals
Humanigen, Inc., a clinical-stage biopharmaceutical company, focuses on preventing and treating an immune hyper-response called cytokine storm'...
Stats | |
---|---|
Dzisiejszy wolumen | 2.06M |
Średni wolumen | 341 846 |
Kapitalizacja rynkowa | 23 816.00 |
EPS | $0 ( 2024-03-28 ) |
Następna data zysków | ( $0 ) 2024-05-13 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.000392 |
ATR14 | $0.00100 (1 000.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-10-18 | Chappell Dale | Sell | 276 210 | Common Stock, $0.001 par value |
2023-10-18 | Chappell Dale | Sell | 75 887 | Common Stock, $0.001 par value |
2023-10-18 | Chappell Dale | Sell | 34 253 | Common Stock, $0.001 par value |
2022-07-27 | Buxton Cheryl | Buy | 78 362 | Stock Option (Right to Buy) |
2022-07-27 | Hohneker John | Buy | 63 195 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
35.49 |
Last 98 transactions |
Buy: 5 830 886 | Sell: 2 957 610 |
Wolumen Korelacja
Humanigen, Inc. Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
RNAZ | 0.961 |
IDEX | 0.96 |
AXDX | 0.953 |
SNAX | 0.95 |
SCPS | 0.948 |
CSSEN | 0.946 |
AHPI | 0.946 |
ALLK | 0.944 |
TIVC | 0.943 |
IRBT | 0.941 |
10 Najbardziej negatywne korelacje | |
---|---|
DSPG | -0.97 |
MRTX | -0.952 |
NTUS | -0.951 |
LMNX | -0.94 |
FRGAP | -0.939 |
DVCR | -0.935 |
STAY | -0.935 |
HCCI | -0.928 |
TAST | -0.925 |
ATVI | -0.919 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Humanigen, Inc. Korelacja - Waluta/Towar
Humanigen, Inc. Finanse
Annual | 2022 |
Przychody: | $2.51M |
Zysk brutto: | $2.51M (100.00 %) |
EPS: | $-1.180 |
FY | 2022 |
Przychody: | $2.51M |
Zysk brutto: | $2.51M (100.00 %) |
EPS: | $-1.180 |
FY | 2021 |
Przychody: | $3.60M |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-3.98 |
FY | 2020 |
Przychody: | $312 000 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-2.42 |
Financial Reports:
No articles found.
Humanigen, Inc.
Humanigen, Inc., a clinical-stage biopharmaceutical company, focuses on preventing and treating an immune hyper-response called cytokine storm'. Lenzilumab is an antibody that binds to and neutralizes granulocyte-macrophage colony-stimulating factor (GM-CSF). The company is developing lenzilumab as a treatment for cytokine storm associated with COVID-19 for which it has completed a Phase 3 study and is the focus of a Phase 2/3 study sponsored by the NIH. It is also developing lenzilumab, which is also being studied in conjunction with CD19-targeted CAR-T cell therapies, as well as exploring the effectiveness of lenzilumab in other inflammatory conditions, such as acute Graft versus Host Disease in patients undergoing allogeneic hematopoietic stem cell transplantation and in eosinophilic asthma, and rheumatoid arthritis. In addition, the company focuses on studying lenzilumab for patients with chronic myelomonocytic leukemia exhibiting RAS pathway mutations. Its pipeline also includes two other Humaneered monoclonal antibodies, ifabotuzumab, which binds to EphA3, and HGEN005, which targets EMR1. Ifabotuzumab has been evaluated in a Phase 1 study of glioblastoma multiforme that showed tumor specific targeting of all known tumor sites with no normal tissue uptake. HGEN005 is being explored as a treatment for a range of eosinophilic diseases, including eosinophilic leukemia as an optimized naked antibody and as the backbone for a novel CAR-T construct. Humanigen, Inc. was incorporated in 2000 and is headquartered in Short Hills, New Jersey.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej